Position in PFE
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,486,837
-$425,115 QoQ
Shares Held
103,274
-0.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#868
of 2,821 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First Pacific Financial holds $27,654,967 across 11 Drug Manufacturers - General names. PFE ranks #5 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
27,850 | $7,008,174 | |
| 2 | NVS |
Novartis AG
|
39,871 | $6,248,583 | |
| 3 | JNJ |
Johnson & Johnson
|
22,381 | $5,684,102 | |
| 4 | MRK |
Merck & Co., Inc.
|
41,379 | $5,317,201 | |
| 5 | PFE |
Pfizer Inc
This page
|
103,274 | $2,486,837 | |
| 6 | NVO |
Novo Nordisk A S
|
10,325 | $494,980 | |
| 7 | LLY |
ELI LILLY & Co
|
249 | $298,658 | |
| 8 | AMGN |
Amgen Inc
|
204 | $73,872 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,486,837 | 103,274 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $2,911,952 | 103,702 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $2,124,393 | 85,317 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $3,206,275 | 125,835 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $2,847,497 | 117,471 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $788,048 | 31,099 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $871,430 | 32,847 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $953,630 | 32,952 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $871,493 | 31,147 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $674,241 | 24,297 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $596,413 | 20,716 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $640,114 | 19,298 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $730,335 | 19,911 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $809,553 | 19,842 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $1,029,667 | 20,095 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,127,126 | 25,757 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $983,953 | 18,767 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $939,211 | 18,142 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $1,077,426 | 18,246 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $794,179 | 18,465 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $700,376 | 17,885 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $553,811 | 15,286 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $436,861 | 11,868 | Shares | Sole | 2021-02-02 | |
| No filing history on record for this holder in this stock. | ||||||